Matches in Nanopublications for { ?s ?p "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP226398.RArYd6-mAFmSAVKRQoLwZLwxn-m2x10jTrh8iKJhSijCM130_assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226398.RArYd6-mAFmSAVKRQoLwZLwxn-m2x10jTrh8iKJhSijCM130_provenance.
- NP455899.RA_IFsEtFL9vYFHtuWjlAncqaIXhTvrinkuDwaZn6ZbR0130_assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455899.RA_IFsEtFL9vYFHtuWjlAncqaIXhTvrinkuDwaZn6ZbR0130_provenance.
- NP410468.RAIxGLVjlniTGea5xZrpuY9ScxLpsTfH6QrggMvSNHVwg130_assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410468.RAIxGLVjlniTGea5xZrpuY9ScxLpsTfH6QrggMvSNHVwg130_provenance.
- NP480761.RAI7AWo2DCjb7TtBjFWVP-vxcvfqtqZAWW4rnUcJRlTro130_assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480761.RAI7AWo2DCjb7TtBjFWVP-vxcvfqtqZAWW4rnUcJRlTro130_provenance.
- NP978579.RAYWC9AUJbF4KUWMsBW-fDs2C_A0ypUKIydNyBBmMaQu0130_assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978579.RAYWC9AUJbF4KUWMsBW-fDs2C_A0ypUKIydNyBBmMaQu0130_provenance.
- NP973595.RAda3fuNtkw6dvMDbBi1IfT5HYCmHInrhjgmhJG8i5xsM130_assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973595.RAda3fuNtkw6dvMDbBi1IfT5HYCmHInrhjgmhJG8i5xsM130_provenance.
- assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP978562.RA9wIzjg7MDwVprIoKw7UOjcNFD94ZjL6iWPqlKZRtIek130_assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978562.RA9wIzjg7MDwVprIoKw7UOjcNFD94ZjL6iWPqlKZRtIek130_provenance.
- NP973594.RA1sWNFi1c5U0MDVQMJFy4m5p65AxfkmqwBJWy3d6rjXw130_assertion description "[We found a high incidence of ASXL1 mutation in MF patients (20%) and a low incidence in PV (7%) and ET (4%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973594.RA1sWNFi1c5U0MDVQMJFy4m5p65AxfkmqwBJWy3d6rjXw130_provenance.